Haemolytic, bacteriostatic and bactericide activity of LfcinB derived peptides.
| Bacterial strain | Peptide (MIC) | Haemolysis (%) | Effect (μM) | |
|---|---|---|---|---|
| Bacteriostatic | Bactericide | |||
| E. coli ATCC 25922 | LfcinB (20–25)2 (6 μM) | 1 | 6 | >24 |
| E. coli ATCC 11775 | LfcinB (20–25)Pal (17 μM) | 5 | 34 | >68 |
| P. aeruginosa ATCC 47853 | LfcinB (20–25)4 (11 μM) | 14 | 11 | 22 |
| S. aureus ATCC 25923 | LfcinB (20–25)4 (22 μM) | 22 | 22 | 44 |
| E. faecalis ATCC 29212 | LfcinB (20–30)4 (30 μM) | 26 | 30 | 120 |